Effects of atenolol versus enalapril on cardiovascular fitness and serum lipids in physically active hypertensive men

American Journal of Cardiology

Volumn 79, Issue 8, 1997, Pages 1065-1069

  Gordon, Neil F ^a   Scott, Christopher B ^b   Duncan, John J ^b  

^a Center for Heart Disease Prevention   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ATENOLOL; BETA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PLACEBO; TRIACYLGLYCEROL;

ADULT; ARTICLE; BLOOD PRESSURE MEASUREMENT; CLINICAL ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; ESSENTIAL HYPERTENSION; EXERCISE; FITNESS; HUMAN; LIPID BLOOD LEVEL; MALE; OXYGEN CONSUMPTION; PHYSICAL ACTIVITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREADMILL EXERCISE;

ANTIHYPERTENSIVE AGENTS; ATENOLOL; CARDIOVASCULAR SYSTEM; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; ENALAPRIL; EXERCISE TEST; HUMANS; HYPERTENSION; LIPIDS; MALE; PHYSICAL FITNESS;

EID: 0030950309     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(97)00048-9     Document Type: Article

References (19)

1. Bostick RM, Luepker RV, Kofron PM, Pirie PL. Changes in physician practice for the prevention of cardiovascular disease. Arch Intern Med 1991;151:478-484.
2. Gordon NF, Duncan JJ. Effect of beta-blockers on exercise physiology: implications for exercise training. Med Sci Sports Exerc 1991;23:668-676.
3. Gordon NF, Cooper KH. Controlling cholesterol levels through exercise. Compr Ther 1988;14:52-57.
4. Kasiske BL, Ma JZ, Kalil RSN, Louis TA. Effects of antihypertensive therapy on serum lipids. Ann Intern Med 1995;122:133-141.
5. Pescatello LS, Buckley T. Letter to the editor. J Cardiopulmonary Rehabil 1995;15:239-240.
6. Pescatello LS, Buckley T. The influence of beta blockade on exercise performance in thermoneutral and warm environments. Med Exerc Nutr Health 1995;4:77-92.
7. Gordon NF, Kohl HW, Villegas JA, Pickett KP, Vaandrager H, Duncan JJ. Effect of rest interval duration on cardiorespiratory responses to hydraulic resistance circuit training. J Cardiopulmonary Rehabil 1989;9:325-330.
8. Jones NL. Evaluation of a microprocessor-controlled exercise testing system. J Appl Physiol 1984;57:1312-1318.
9. Duncan JJ, Vaandrager H, Farr JE, Kohl HW, Gordon NF. Effect of intrinsic sympathomimetic activity on serum lipids during exercise training in hypertensive patients receiving chronic beta-blocker therapy. J Cardiopulmonary Rehabil 1989;9:110-114.
10. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972;18:499-502.
11. Leon AS, McNaily C, Casal D, Grimm R, Crow R, Bell C, Hunninghake DB. Enalapril alone and in combination with hydrochlorothiazide: effect on treadmill exercise performance. J Cardiopulmonary Rehabil 1986;7: 251-256.
12. Wilmore JH. Exercise testing, training, and beta-adrenergic blockade. Physician Sportsmed 1988;16:45-52.
13. Davies SF, Graif JL, Husebye DG, Maddy MM, McArthur CD, Path MG, O'Connell MB, Iber C, Davidman M. Comparative effects of transdermal clonidine and oral atenolol on acute exercise performance and response to aerobic conditioning in subjects with hypertension. Arch Intern Med 1989;149:1551-1556.
14. Gordon NF, Myburgh DP, Neutel JM, Bernitz H, Cilliers JF. Comparison of captopril and conventional step 1 antihypertensive therapy: effects on exercise performance. J Cardiopulmonary Rehabil 1988;8:108-115.
15. Myburgh DP, Gordon NF. Comparison of diltiazem and atenolol in young, physically active men with essential hypertension. Am J Cardiol 1987;60:1092-1095.
16. Thompson PD, Cullinane EM, Nugent AM, Sady MA, Sady SP. Effect of atenolol or prazosin on maximal exercise performance in hypertensive joggers. Am J Med 1989(suppl 1B);86:104-109.
17. Morton AR, Stanforth PR, Freund BJ, Joyner MJ, Jilka SM, Hartzell AA, Ewy GA, Wilmore JH. Alterations in plasma lipids consequent to endurance training and beta-blockade. Med Sci Sports Exerc 1989;21:288-292.
18. Ferrari P, Rosman J, Weidmann P. Antihypertensive agents, serum lipoproteins and glucose metabolism. Am J Cardiol 1991;67:26B-35B.
19. Grimm RH Jr, Flack JM, Grandits GA, Elmer PJ, Neaton JD, Cutler JA, Lewis C, McDonald R, Schoenberger J, Stamler J. Long-term effects on plasma lipids of diet and drugs to treat hypertension. JAMA 1996; 275:1549-1556.